✦ LIBER ✦

PSY27 THE LONG-TERM COST OF ORTHOPAEDIC SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN HAEMOPHILIA INHIBITOR PATIENTS

✍ Scribed by Å Ericsson; M Haglund

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant activated factor VII for hae

✍ A. OBERGFELL; M.-K. AUVINEN; P. MATHEW 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Experience of recombinant activated fact

✍ T. Polyanskaya; V. Zorenko; E. Karpov; M. Sampiev; G. Mishin; D. Vasiliev 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Long-term follow-up of prophylaxis with

✍ B. JENABALI JAHROMI; M. KARIMI 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Results of the WIRK prospective, non-int

✍ Birschmann, I.; Klamroth, R.; Eichler, H.; Schenk, J.; Kirchmaier, C. M.; Halime 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Safety and efficacy of recombinant activ

✍ Chuansumrit, A.; Sirachainan, N.; Panuwannakorn, M.; Wongwerawattanakoon, P.; Ka 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Consensus protocol for the use of recomb

✍ P. L. F. GIANGRANDE; J. T. WILDE; B. MADAN; C. A. LUDLAM; E. G. D. TUDDENHAM; N. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB